A protein that could regenerate heart tissue and a new treatment for diabetes and obesity have taken top honors from the Wisconsin Alumni Research Foundation (WARF), according to a press release.
The first 2023 WARF Innovation Award has been given to UW–Madison’s Ahmed Mahmoud, assistant professor of cell and regenerative biology; Timothy Kamp, professor of cardiology; and Youngsook Lee, associate professor of cell and regenerative biology, for their work, Regenerating and Renewing Heart Tissue.
The team discovered a protein, LRRC10, that activates heart renewal and regeneration in animal models. This discovery could lead to a therapeutic that restores cardiac structure and function in human heart failure patients.
The other winning team includes Samuel Gellman, professor of chemistry; postdoc Kyle Brown; and graduate student Rylie Morris for their work, Potent New Drug for Type 2 Diabetes, Obesity.
With the commercial success of two well-known brands, pharmaceutical companies have an intense interest in additional therapeutics for the treatment of both obesity and type 2 diabetes. This team of chemists developed a synthetic peptide that uses a more simplified design to target the same mechanisms of the drugs currently on the market.
An independent panel of judges selected the winners from a field of six finalists drawn from several hundred invention disclosures submitted to WARF over the prior 12 months. The winning teams each receive an award of $10,000, with the funds going to the named UW–Madison inventors.
